MUNDIPHARMA'S Akynzeo (netupitant with palonosetron) has been added to the Pharmaceutical Benefits Scheme for nausea and vomiting, effective 01 Jun.
The listing is a streamlined authority required - see pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jun 17